John E. Ray

5.4k citations
92 papers · 4.1k · 1 hit paper · h-index 32

Impact in

Papers in

    • Diverticular Disease and Complications 9
    • Gastrointestinal disorders and treatments 8
    • HIV/AIDS drug development and treatment 14
    • Antifungal resistance and susceptibility 11
    • HIV/AIDS Research and Interventions 8

John E. Ray

90 papers receiving 3.9k citations

John E. Ray's Hit Papers

Clinical Pharmacokinetics of Metformin 2011 · 979 citations
9790+5+10Years since publication250500750

Peers

John E. Ray
Comparison fields: 5 of 148
  • Infectious Diseases 1.1k
  • Virology 218
  • Transplantation 101
  • Oncology 917
  • Epidemiology 995
Replace Saı̈k Urien with:
Saı̈k Urien France
Gilbert Deray France
Hassane Izzedine France
Thomas Marbury United States
Dominique Larrey France
Massimiliano Berretta Italy
Peter Angus Australia
Kathrin Klein Germany
W. Harry Hannon United States
Lee A. Hebert United States
John E. Ray relative to Saı̈k Urien France Saı̈k Urien's profile →
Citations per field
00.5×1.6×
Saı̈k Urien · 1×
Citations per year

Countries citing papers authored by John E. Ray

Since Specialization
Citations

This map shows the geographic impact of John E. Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Ray more than expected).

Fields of papers citing papers by John E. Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Ray. The network helps show where John E. Ray may publish in the future.

Co-authors

The 25 scholars most cited alongside John E. Ray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John E. Ray Line = papers co-authored together John E. Ray links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clinical Pharmacokinetics of Metformin
Hit paper breakdown →
2011979
2 2012228
3
Endometriosis of the bowel.
1987174
4 1992164
5 1993157
6 2012156
7 2009131
8 2012116
9 1992115
10 2006114
11 197988
12 201478
13 200568
14 200355
15 198951
16 197551
17 199151
18 200650
19 200550
20 200849

About John E. Ray

John E. Ray is a scholar working on Surgery, Infectious Diseases, Epidemiology, Oncology and Pharmacology, having authored 92 papers that have together received 4.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (13 papers), Antifungal resistance and susceptibility (11 papers), Diverticular Disease and Complications (9 papers), HIV/AIDS Research and Interventions (8 papers), Gastrointestinal disorders and treatments (8 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Colorectal Cancer Surgical Treatments (7 papers). The work is most often cited by research in Infectious Diseases (1.1k citations), Virology (218 citations), Transplantation (101 citations), Oncology (917 citations) and Epidemiology (995 citations). John E. Ray has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Andrew J. McLachlan, Alan E. Timmcke, Michael Dolton, Richard O. Day, Byron J. Gathright, Deborah Marriott, John C. Weed, Garry G. Graham, Kenneth M. Williams and Jerry R. Greenfield. Their work appears in journals such as Diseases of the Colon & Rectum, Therapeutic Drug Monitoring, Antimicrobial Agents and Chemotherapy, Journal of NeuroVirology and HIV Clinical Trials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact